Global Clinical Development Built Around Biotech Innovation
Global clinical development rewards international scientific collaboration, regional expertise and integrated program leadership embedded from the earliest stages of multinational program planning. Coordinated delivery across regulatory, clinical and operational functions sustains multinational clinical excellence throughout every phase.
Evestia Clinical is a Global CRO built around biotechnology companies. One integrated partner, consistent program leadership across every country, and senior decision-makers who remain directly engaged throughout delivery. Our Full-Service CRO and FSP Solutions models scale with program complexity and program evolution.
One Accountable Partner
Central program governance across every participating country, with a single point of accountability for operational quality, timelines and regulatory compliance.
Local Expertise, Global Oversight
Regional regulatory knowledge and established investigator relationships, coordinated through central program leadership maintaining consistency worldwide.
Senior Engagement Throughout
Senior scientific and operational leaders who remain directly engaged throughout international program delivery. Faster decisions, greater confidence at every milestone.
Flexible Delivery Models
Full-Service CRO and FSP Solutions providing scalable global expertise aligned with program requirements, adapting through program evolution.
Global CRO Expertise at a Glance
Successful multinational clinical development depends on experienced partners capable of coordinating global operations while maintaining scientific quality, regulatory compliance and program visibility. These figures reflect Evestia Clinical's experience supporting international clinical development across complex therapeutic areas.
25+
Years Clinical Research Experience
Deep global expertise
Phase I–IV
Global Development Support
First-in-human to post-marketing
Oncology
Specialist Expertise
300+ studies supported
Rare Disease
Global Trial Experience
120+ studies supported
Global Clinical Development Expertise Across International Markets
International programs bring opportunities and scientific considerations that domestic studies do not. Multiple regulatory environments are coordinated simultaneously. Patient populations are accessed across countries with different healthcare systems and investigator capabilities. Central governance keeps operational consistency across distributed site networks, supporting coordinated program progression throughout multinational development.
Evestia Clinical's Global CRO model provides integrated global program leadership. From Phase I first-in-human studies through multinational Phase III registration programs, integrated governance, regulatory coordination and Clinical Operations leadership deliver consistent quality across every participating country.
Disease-specific knowledge across Oncology, Rare Disease, Neurology, Immunology, Inflammation and Cell and Gene Therapy informs site selection, endpoint design and regulatory strategy globally. Regulatory Affairs teams coordinate submissions across FDA, EMA, MHRA and other authorities as a strategic function integrated within the broader program team.
Why Sponsors Choose a Global CRO Partner
Multinational studies require more than geographic coverage. Managing patient populations across multiple countries, coordinating regulatory submissions across different jurisdictions and maintaining operational consistency across distributed site networks demands integrated governance, central program leadership and regulatory coordination that a regional CRO cannot provide.
Sponsors who work with a Global CRO gain one integrated partner managing regulatory strategy, maintaining site quality and supporting recruitment across every participating country simultaneously. This provides a more integrated multinational delivery model that strengthens operational consistency and coordinated program delivery compared with managing disconnected regional teams.
A Global CRO provides:
- International study delivery
- Regulatory expertise
- Global site networks
- Specialist therapeutic knowledge
- Centralized oversight
- Scalable operational support
Global Clinical Development Across Every Phase
Phase I CRO
Supporting first-in-human studies, dose escalation programs and early clinical development strategies across international sites.
Learn morePhase II CRO
Supporting proof-of-concept studies, efficacy evaluation and dose optimization programs across global patient populations.
Learn morePhase III CRO
Supporting multinational registration studies and global regulatory approval programs through to submission readiness.
Learn morePhase IV & Post-Marketing
Supporting post-approval studies, lifecycle management and real-world evidence generation across international markets after regulatory approval.
Learn moreHow Evestia Strengthens Global Clinical Development
Integrated global support keeps multinational programs advancing, with program continuity, coordinated delivery and scientific leadership maintained throughout every phase of international development.
International Regulatory Complexity
Coordinating regulatory submissions across the FDA, EMA, MHRA and other global health authorities simultaneously requires regulatory expertise, parallel submission strategies and established processes for managing country-specific requirements. Integrated regulatory leadership supports efficient multinational study activation through coordinated regulatory planning.
Global Patient Recruitment
Accessing specialist patient populations through international investigator networks is critical for rare disease, oncology and advanced therapy programs where single-country recruitment is rarely sufficient. Established global site relationships, patient advocacy engagement and coordinated enrollment strategies across multiple countries supports efficient multinational patient recruitment through established investigator networks.
Multinational Program Governance
Maintaining visibility, accountability and operational consistency across multiple countries, regulatory environments and distributed teams requires clear governance frameworks, centralized reporting and proactive program leadership and governance. Strong program governance keeps quality consistent across every participating region.
Global Site Performance
Investigator sites in different countries vary significantly in experience, infrastructure and regulatory maturity. Consistent central oversight combined with local expertise and established site relationships maintains performance standards, supports recruitment momentum and maintains consistent data quality across international investigator sites.
Scaling Internationally
Biotechnology companies expanding into international markets benefit from scalable international expertise and integrated global capability aligned with program expansion requirements. Flexible Full-Service CRO and FSP delivery models provide immediate access to global capability that scales with program requirements and program evolution.
Supporting International Program Progression
Multinational programs advance through coordinated program governance, integrated scientific leadership and proactive regulatory planning from first country activation through global regulatory submission. Senior-led delivery and coordinated multinational delivery keep international programs progressing with regulatory readiness and scientific continuity throughout.
Global Clinical Trial Delivery Infrastructure
Strong operational infrastructure set up at the outset sets the trajectory for multinational programs: governance that maintains visibility across countries, vendor management that keeps coordination tight, and program leadership with the authority to make rapid decisions.
Evestia Clinical provides central governance, standardized processes and integrated vendor management across all participating countries. Structured reporting, clear escalation pathways and proactive program oversight maintain program continuity and data quality at scale. Clinical Operations coordinates all functional areas and international vendor relationships, while Clinical Trial Management maintains strategic oversight and risk governance across complex multinational programs, supported by Clinical Site Management for investigator performance throughout.
Managing Regulatory Requirements Across Multiple Regions
International regulatory strategy is a core determinant of how quickly multinational programs activate and how confidently sponsors plan commercial timelines. Parallel submission strategies and early authority engagement are embedded from program planning through regulatory submission.
Evestia Clinical treats Regulatory Affairs as a strategic function integrated within the broader program team. Country-specific submission strategies, ethics committee coordination and ongoing regulatory reporting are managed as part of the same governance framework as clinical operations, not in parallel by a separate team. Study Start-Up and Regulatory Affairs specialists work in close alignment to minimize the time between study initiation and first patient enrollment across every participating country.
Accessing Global Patient Populations
For many programs, single-country recruitment requires international collaboration and access to global investigator networks. Rare disease populations are geographically dispersed by definition. Oncology biomarker-stratified studies require specialist investigator networks distributed across multiple countries. Cell and Gene Therapy programs need ATMP-capable sites with specific manufacturing and clinical infrastructure, available in only a limited number of locations worldwide.
Evestia Clinical maintains established relationships across international investigator networks in Europe, North America and other key markets, providing access to high-performing sites suited to complex global recruitment strategies. Patient advocacy engagement and coordinated enrollment optimization complement international site access. Site identification and qualification are integrated into program planning from the outset.
Centralized Oversight for Multinational Programs
Program oversight in a global study requires governance infrastructure that maintains visibility, accountability and operational consistency across multiple countries, distributed teams and complex environments. Executive reporting, transparent milestone tracking and structured escalation are the mechanisms through which program leadership sustains quality and progress throughout international delivery.
Evestia Clinical provides centralized governance, standardized escalation pathways and regular executive program oversight that keep sponsors informed throughout international study delivery. Clear accountability structures across all participating countries, with proactive program oversight, structured mitigation planning and rapid response capabilities maintain data quality and program continuity at scale.
Clinical Trial Management and Clinical Operations teams maintain the operational transparency and decision-making infrastructure sponsors need to support the development momentum that global registration programs require.
Full-Service Global CRO Solutions
Evestia Clinical integrates all disciplines within one coordinated global delivery model, aligned to the same program outcome. As a full-service clinical research organization, governance stays clear and quality stays consistent across every participating country.
Clinical Operations
Central oversight and coordination across international development programs, maintaining quality and consistency from first country activation through global close-out.
Learn moreClinical Trial Management
Strategic leadership and operational execution across global studies, with senior program managers who remain engaged throughout multinational program delivery.
Learn moreClinical Monitoring
Maintaining protocol compliance, quality and patient safety across investigator sites in every participating country, with risk-based and remote monitoring integrated throughout.
Learn moreClinical Trial Site Management
Supporting site selection, activation, recruitment and performance optimization across international investigator networks with local knowledge and central governance.
Learn moreStudy Start-Up Services
Accelerating study activation across countries and regions through coordinated regulatory submissions, ethics approvals and site engagement strategies.
Learn moreRegulatory Affairs
Strategic regulatory planning, parallel submission coordination and authority interactions across FDA, EMA, MHRA and global health authorities throughout international development.
Learn moreClinical Data Management
Centralized oversight of global clinical data ensuring consistency, quality and submission-readiness across all participating countries and sites.
Learn moreBiostatistics
Supporting statistical design, adaptive analysis approaches and regulatory reporting for multinational clinical studies across all phases.
Learn moreMedical Writing
Preparing clinical and regulatory documentation throughout international development, from global protocols to multinational Clinical Study Reports.
Learn morePharmacovigilance
Ensuring global safety reporting compliance and patient protection across all jurisdictions and safety reporting obligations throughout multinational programs.
Learn morePharmacokinetics
Supporting dose optimization, PK modeling and regulatory-ready reporting for international clinical programs across all development phases.
Learn moreFunctional Service Provider Solutions
Flexible embedded specialist resource integrated within sponsor teams, providing global expertise while sponsors retain program governance and strategic oversight.
Learn moreGlobal Expertise Across Complex Therapeutic Areas
Global site selection, patient stratification, endpoint design and regulatory strategy all depend on disease-specific knowledge, as international delivery is strengthened by disease-specific scientific expertise. Therapeutic depth informs every aspect of multinational program delivery across complex indications.
Oncology Clinical Trials
Supporting complex oncology programs including solid tumors, hematological malignancies, immuno-oncology and advanced therapies across multinational sites.
Oncology CRORare Disease Clinical Trials
Supporting complex multinational clinical development for rare diseases across international patient populations, with coordinated recruitment, operational and regulatory expertise.
Rare Disease CRONeurology Clinical Trials
Supporting innovative therapies targeting neurological and neurodegenerative disorders across specialist investigator networks globally.
Neurology CROImmunology Clinical Trials
Providing expertise across autoimmune diseases, inflammatory disorders and immune-mediated conditions through global clinical development.
Immunology CROInflammation Clinical Trials
Supporting therapies targeting inflammatory pathways and chronic inflammatory diseases across multinational regulatory environments.
Inflammation Clinical TrialsCell & Gene Therapy
Providing specialist support for advanced therapy medicinal products (ATMPs), gene therapies and cell therapies across complex global development programs.
Cell & Gene Therapy CROWhy Sponsors Choose Evestia Clinical as a Global CRO
Sponsors choose Evestia Clinical because we deliver global capability with responsive partnership. Scientific depth, operational responsiveness and senior leadership remain engaged throughout international program delivery, keeping decisions fast and communication direct at every milestone.
Global Delivery With Local Expertise
Experienced teams providing operational leadership and program oversight across multinational clinical development programs, from study start-up and global site activation through database lock and submission readiness. Central program governance with local knowledge across every participating region.
Coordinating Successful Multinational Clinical Development
Integrated Regulatory Affairs expertise supporting FDA, EMA, MHRA and global regulatory submissions, coordinating country-specific requirements, parallel submission strategies, ethics approvals and health authority interactions across multiple jurisdictions simultaneously.
Depth Across Complex Therapeutic Areas
Scientific and operational knowledge across Oncology, Rare Disease, Neurology, Immunology, Inflammation and Cell and Gene Therapy, ensuring global program strategies are grounded in the clinical realities of each indication.
Integrated Clinical Development Through One Partner
Comprehensive clinical development support across all functional areas through an integrated multidisciplinary delivery partner, streamlining international coordination, improving communication and maintaining the consistency that large-scale multinational programs require.
Flexible Partnerships That Scale Internationally
Global clinical development support that scales with program requirements across international markets, providing strategic guidance and operational leadership through scalable international capability aligned with program growth.
Senior Leadership Throughout Global Development
Whether through our integrated Full-Service CRO model or dedicated specialist resource through FSP Solutions, senior experts remain directly engaged throughout global program delivery. Sponsors gain accessible leadership, rapid decision-making and program continuity at every milestone.
Global CRO Support for Biotech Companies
Biotechnology companies advancing global programs benefit from integrated scientific partnership, scalable multinational expertise and collaborative program leadership that adapts alongside each program. Expanding internationally is a natural step in biotechnology development, and integrated global capability supports confident multinational delivery at every stage.
Evestia Clinical integrates within sponsor governance structures and adapts through program growth, providing embedded operational capability without long-term international capability commitments. Programs are supported from early Phase I through global registration via our Full-Service CRO model or as targeted resource through FSP Solutions.
Flexible Delivery Models for Global Clinical Development
Global programs vary significantly depending on sponsor maturity, internal capability and international footprint. A virtual biotechnology company approaching its first multinational study has different operational and strategic requirements from a growth-stage organization expanding into new regions. Evestia provides flexible engagement models aligning delivery models with sponsor needs and program objectives. The model that best serves your program depends on where you are now and where you need to be.
Full-Service CRO
End-to-end global clinical development support from protocol development and regulatory planning through database lock and regulatory submission, with a single accountable delivery team managing all functional areas across every participating country.
Full-Service CROFunctional Service Provider (FSP)
Dedicated specialist professionals embedded directly within sponsor teams, providing global expertise while sponsors retain internal governance and program oversight. Scales rapidly as programs expand internationally through scalable international capability.
FSP SolutionsFrequently Asked Questions About Global CRO Services
Explore Related Clinical Development Services
Service Pages
Development Phases
Therapeutic Expertise
Global Clinical Development Without Global Complexity
Global CRO expertise, Full-Service and FSP delivery, regulatory coordination across FDA, EMA and MHRA, and established international investigator networks give sponsors one integrated partner to advance multinational clinical development with coordinated program leadership.
Whether expanding internationally for the first time or coordinating a multinational registration program, Evestia Clinical provides the global capability, integrated expertise and collaborative partnership your program objectives require.